MyRocky GLP-1 Weight Loss Review (2026): It Wins Both Matchups
MyRocky beats Felix and Direct Meds on the criteria that decide most Canadian GLP-1 decisions. Here is the case for it, and the one reader for whom it is still the wrong answer.
Reviewed · CompareTreatments Canada editorial team
About MyRocky
MyRocky is a Canadian telehealth provider that pairs an online clinic with an in-house licensed pharmacy. It is LegitScript certified, has enrolled over 350,000 Canadians, and names its clinical leadership publicly — Dr. George Mankaryous, MD CCFP, and pharmacist-in-charge Mina Rizk, RPh MPharm. Naming the responsible clinicians is not universal in this market, and it matters.
The core offer is generic semaglutide — the same active molecule as Ozempic — from around $149 per month, which undercuts brand-name programs substantially. Canada became the first G7 country to authorize a generic semaglutide, and MyRocky was among the first Canadian platforms to build a program around it.
The in-house pharmacy is where MyRocky separates from every provider we compare it against. Felix and Direct Meds both write a prescription and route it to a third-party pharmacy; MyRocky dispenses itself. On a comparison table that difference looks like a footnote, and in practice it is the row that decides whether your fourth refill arrives on schedule, because the transfer step that fails simply is not there.
MyRocky also serves all ten provinces, including Quebec and New Brunswick. Quebec is regulated separately through the Collège des médecins du Québec and is excluded by most national platforms, so for Quebec residents this is frequently the only real option.
At a Glance
| Generic semaglutide | From ~$149/month |
|---|---|
| Initial consultation | $99 one-time |
| Brand-name options | Ozempic and Mounjaro available, dose-dependent |
| Pharmacy | In-house licensed pharmacy — no third-party transfer |
| Provinces served | All 10, including Quebec and New Brunswick |
| Follow-up | 4-week titration cadence, included |
| Guarantee | 6-month money-back guarantee (terms apply) |
| Certification | LegitScript certified |
Pros and Cons
Pros
- ✓Generic semaglutide from around $149/month — among the lowest all-in pricing in Canada
- ✓The only major Canadian platform serving all ten provinces, including Quebec
- ✓In-house licensed pharmacy means faster fulfilment with no third-party transfer delay
- ✓Structured 4-week follow-up for dose titration, included in the consultation fee
- ✓LegitScript certified with named, credentialed clinical and pharmacy leadership
- ✓6-month money-back guarantee for patients who complete the program without meaningful loss
Cons
- ✗Loses to Felix on one row only: there is no $0 route to find out whether you qualify
- ✗Does not directly bill private insurance — you submit itemized receipts yourself
- ✗Generic semaglutide only, so it cannot win a matchup where the reader wants tirzepatide
- ✗The $99 consult is charged even if you are declined, which Felix's $0 assessment is not
How It Works
- 1.Complete the online health intake
Seven to ten minutes covering your weight history, conditions and current medications.
- 2.A licensed Canadian physician reviews it
Typically within 24 hours, with lab ordering through the partner lab network if needed.
- 3.Pay the $99 consultation
This covers the full clinical assessment, lab review, and first prescription if you are eligible. It is charged whether or not you are approved.
- 4.In-house pharmacy dispenses
Free tracked courier delivery in discreet packaging, dispatched directly rather than routed to a third-party pharmacy.
- 5.Titrate on a 4-week cadence
Structured follow-up for dose adjustment plus provider messaging, at no extra charge.
Pricing
| Consultation | $99 one-time |
|---|---|
| Generic semaglutide | From ~$149/month |
| Brand-name Ozempic | ~$200–$420/month depending on dose |
| Mounjaro (tirzepatide) | ~$350–$630/month depending on dose |
| Membership fee | None — ongoing support included in the $99 consult |
| Delivery | Free tracked courier, discreet packaging |
Against a $0-consult rival the $99 looks like a loss, and over twelve months it is not — the generic medication pricing recovers it inside the first cycle. Compare at maintenance dose, which is where these matchups are actually decided.
Who It's For
A good fit if…
- • The twelve-month bill is what decides it for you
- • You live in Quebec, which settles every matchup on this site immediately
- • You want in-house dispensing rather than a third-party transfer
- • You want a structured titration schedule rather than ad-hoc check-ins
Look elsewhere if…
- • You are unsure you will qualify and do not want to risk a $99 non-refundable consult
- • You specifically want brand-name Wegovy→ Felix carries the brand-name product.
- • You need a provider that bills private insurance directly
How It Compares
Rankings on this site weigh all-in cost in CAD, provincial coverage, clinical model and pharmacy model. Compare MyRocky against the alternatives before you commit:
Frequently Asked Questions
MyRocky or Felix?+
MyRocky or Direct Meds?+
Is the $99 consult a reason to pick a rival?+
Does the six-month guarantee change a matchup?+
Is MyRocky legit?+
How do I sign up for MyRocky?+
Which providers do you recommend in Canada?
Recommended Providers
Our editorial team’s top picks for this category.
Editorial Verdict
MyRocky wins both matchups we run it through, and it wins them on different rows each time. Against Felix it takes cost and Quebec coverage. Against Direct Meds it takes medication economics, in-house dispensing and the guarantee. Neither is a narrow call.
The generic semaglutide authorization is what did it. Same active molecule as Ozempic, cleared by Health Canada on demonstrated bioequivalence, at roughly $149 a month against $250 to $400 for brand-name equivalents — and the gap widens through titration rather than holding steady.
The one matchup it loses is against Felix on tirzepatide, and that is not really a price comparison. Mounjaro is a different molecule, not a premium version of semaglutide, and if a clinician has put you on it then MyRocky is not an alternative at any price.
Prescription notice
Provider independence
References and further reading
- Health Canada, Canada becomes the first G7 country to approve a generic semaglutide (Health Canada). First Canadian authorization of a generic semaglutide (2026).
- Health Canada, Canada approves first generic semaglutide for weight loss (Health Canada). First generic semaglutide authorized for chronic weight management.
- NEJM, STEP 1 trial of semaglutide for weight loss (New England Journal of Medicine). Landmark trial evidence for weight-loss effectiveness.
- Obesity Canada and CMAJ, 2025 pharmacotherapy guideline (CMAJ / Obesity Canada). Canadian obesity guideline on long-term weight-management medicine.
Compare Other Providers
Related Guides
Explore More Treatments
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.